From: Treatment length and outcomes among adolescents: a secondary data analysis
Variable | Adjusted OR (95% CI) | Chi-square |
---|---|---|
No. of sessions |  | χ22 = 25.13** |
5 sessions | Referent | p = <0.0001 |
<5 sessions | 0.37 (0.23, 0.60) | Â |
>5 sessions | 0.35 (0.22, 0.53) | Â |
Race/Ethnicity |  | χ12 = 7.13* |
 |  | p = 0.0076 |
Non-Whites | Referent | Â |
Whites | 1.52 (1.12, 2.08) | Â |
Gender |  | χ12 = 0.52 |
 |  | p = 0.4688 |
Male | Referent | 0 |
Female | 0.89 (0.66, 1.21) | Â |
Age @ baseline |  | χ22 = 0.13 |
 |  | p = 0.9393 |
10-14 | Referent | 7 |
15-17 | 1.00 (0.70, 1.43) | Â |
18-22 | 1.11 (0.57, 2.13) | Â |
GISS Scores |  | χ22 = 12.31** |
 |  | p = 0.0021 |
Low - 0 | Referent | 0 |
Moderate - 1 | 0.90 (0.65, 1.24) | Â |
High - 2 | 0.50 (0.34, 0.74) | Â |
Substance Frequency Scale (3 months) |  | χ22 = 27.05** |
 |  | p < 0.0001 |
0 | Referent | Â |
0.01 – 0.13 | 0.62 (0.44 – 0.86) |  |
0.13 – 1.00 | 0.31 (0.20 – 0.48) |  |